Abstract

Background: Lower vitamin D levels have not only been associated with chronic obstructive pulmonary disease (COPD), exacerbations and lower lung functions, but also with anxiety and depression. We examined the associations of severity of anxiety and depression using HAM-A (Hamilton Anxiety Rating Scale) and HAM-D (Hamilton Depression Rating Scale) scores with COPD and vitamin D levels. Methods: Observational nested case control study was conducted in MUDHRA cohort. One hundred COPD subjects and 100 age- gender- matched non-COPD subjects (controls) underwent evaluation of socioeconomic status, respiratory symptoms, spirometry, severity of anxiety and depression, six minute walk test and estimation of serum vitamin D levels. Independent association of low vitamin D levels with severity of anxiety and depression was assessed by logistic regression. Results: COPD group had higher mean±SD anxiety and depression scores (HAM-A 8.0±3.5, HAM-D 8.72±4) compared to control group (HAM-A 4.51±2.2, HAM-D 4.3±2). The COPD group had 53 subjects with mild/moderate anxiety/depression whereas control group had 16 subjects with mild/moderate anxiety/depression. In COPD group, subjects with mild/moderate anxiety/depression had lower vitamin D levels compared to subjects with no/minimal anxiety/depression, while the difference in control group was not significant. In logistic regression, anxiety and depression levels had independent association with vitamin D levels, lung function variables, six-minute walk distance and presence of COPD. In COPD subgroup, anxiety and depression levels had independent association with breathlessness, GOLD FEV1 staging, CAT score, SGRQ-C Symptom score and exacerbation of COPD. Conclusions: Greater proportion of COPD subjects suffer from anxiety and depression as compared to subjects without COPD. Severity of anxiety and depression was greater in COPD subjects. Poorer lung functions, higher respiratory symptoms and lower vitamin D levels are associated with higher levels of anxiety and depression in COPD subjects. There is an urgent need to recognise anxiety and depression in COPD patients.

Highlights

  • Chronic Obstructive Pulmonary Disease (COPD) is a well-recognised non-communicable disease (NCD) characterised by dyspnoea and near irreversible airflow limitation

  • In chronic obstructive pulmonary disease (COPD) group, subjects with mild/moderate anxiety/depression had lower vitamin D levels compared to subjects with no/minimal anxiety/depression, while the difference in control group was not significant

  • Higher respiratory symptoms and lower vitamin D levels are associated with higher levels of anxiety and depression in COPD subjects

Read more

Summary

Results

84 subjects had no/ minimal anxiety or depression; whereas in COPD group, 53 patients had mild/moderate anxiety or depression. In the COPD group, a significant difference in mean vitamin D levels was observed between the subjects of no/minimal anxiety or depression, compared to mild/moderate anxiety or depression (p-value

Introduction
Methods
Discussion
Presence of COPD Exacerbations
Strengths and limitations
Conclusion
India State-Level Disease Burden Initiative CRD Collaborators
17. Lokesh KS
19. Hamilton M
30. Global Initiative for Chronic Obstructive Lung Disease 2014 Report
43. Miller AH: Mechanisms of cytokine-induced behavioral changes
56. Spedding S
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call